Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
321 participants
INTERVENTIONAL
2017-03-04
2022-01-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study examines whether two behavioral weight-management programs can help people maintain weight loss over time. In this study, 346 adults will be randomly assigned (like flipping a coin) to one of the 12-month programs and followed for 36 months (i.e., 3 years) to see how their body weight may change.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Healthy Weight With 'Stability Skills First'
NCT00626457
Exercise Adherence in a Behavioral Weight Loss Program
NCT00005743
Adherence to Weight Loss for Hypertension in African American Women
NCT00142649
Promoting Long-term Behavior Change to Reduce CVD Risk
NCT00227006
Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment (STEADY)
NCT04751656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Overweight/obese individuals with elevated blood pressure will be randomized to one of two 12-month weight-management interventions (Fun First or Weight Watchers) and followed for 36 months. For Aim 1 (Primary outcome), we will test whether Fun First is more efficacious than Weight Watchers using a mediator-intervention interaction model with sufficient a priori statistical power for the interaction effect as well as the intervention and mediator main effects. The posited mediator assesses participants' change in enjoyment for four key healthy lifestyle behaviors (healthy eating, physical activity, weighing and self-nurturing) via online survey from 0-2 months. The primary outcome is the proportion of participants who lose a clinically significant amount of initial body weight and maintain it during the trial (i.e., lose \>=7% of their initial body weight from 0-12 months and gain \<=5 lbs from 12-36 months), assessed on clinic scales during in-person visits at the research clinic. Secondary outcomes include the proportion of individuals sustaining ≥7% weight loss over the trial assessed by digital cellular scales in participants' homes and participants' change in systolic blood pressure over the trial assessed at the research clinic.
For Aim 2 (Other pre-specified outcomes), we will test whether Fun First is more cost effective than Weight Watchers using both individual-level trial data and systems science modeling for long-term, population-level hypertension and cardiovascular disease incidence, health care and disability costs, and quality-adjusted life-years over the life course.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fun First
If randomized to the 12-month Fun First program, participants will attend weekly interactive small-group sessions led by health coaches for 6 months, then receive monthly phone calls from coaches for 6 months. The first 6 months consists of a 2-month module promoting enjoyment of key maintenance skills before losing weight, followed by a 4-month behavioral weight-loss program.
Fun First
Learn key enjoyable maintenance skills before losing weight
Weight Watchers
If randomized to the 12-month Weight Watchers program, participants are provided with study-paid access to weekly ongoing Weight Watchers meetings led by peer meeting leaders for 12 months at Weight Watchers locations convenient to participants as well as study-paid access to Weight Watchers personalized online tools. \[The study and investigative team have no financial relationship with Weight Watchers\].
Weight Watchers
Focus on losing weight first via convenient meetings and personalized online tools
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fun First
Learn key enjoyable maintenance skills before losing weight
Weight Watchers
Focus on losing weight first via convenient meetings and personalized online tools
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systolic blood pressure between 120-159 mmHg OR diastolic blood pressure between 80-99 mmHg. Can be on \>=1 antihypertensive medications if on stable dose for past 3 months
* Systolic blood pressure \<120 mmHg OR diastolic blood pressure \<80 mmHg, if on stable dose of \>=1 antihypertensive medications for past 3 months
Exclusion Criteria
* Have had a heart attack, stroke, coronary heart disease, congestive heart failure, or angina
* Have had coronary artery bypass surgery or cardiac catheterization such as percutaneous transluminal coronary angioplasty (PTCA), cath or stent placement
* Have diabetes
* Have medical contraindications to regular, unsupervised physical activity
* Have moderate to severe asthma, or chronic obstructive pulmonary disorder (also called emphysema or chronic bronchitis)
* Had cancer in the past 5 years (except non-melanoma skin cancer)
* Currently under medical care for digestive issues, gastrointestinal distress, abdominal pain, or diarrhea
* Had an organ transplant
* Not stable on medications over the past 3 months (e.g., cholesterol, thyroid, estrogen-hormone, psychiatric)
* Currently taking prescription pain medications (e.g., Vicodin, Oxycodone)
* Have binge eating disorder or bulimic compensatory symptoms
* Currently taking medication designed to lose weight
* Have undergone weight-loss surgery (e.g., gastric bypass, lap band)
* Have lost \>10 pounds in the past 6 months
* Currently in a weight-loss program (e.g., Jenny Craig)
* Currently participating in any support groups that focus on weight or eating habits (e.g., Overeaters Anonymous)
* Currently on a special diet for a serious health condition
* Not willing to discontinue a special diet (e.g., Atkins)
* Planning to move in the next year
* Currently pregnant or planning to be within the next year
* Participating in another research study
* No regular access to a mobile phone and Internet
* Not able to speak, read, or understand English for informed consent
* Not willing to be randomized
* Did not complete eligibility process successfully or in a timely manner
* Staff discretion or judgement
* Live within Bay Area (e.g., \~1-hour commute from Stanford research center)
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michaela Kiernan
Senior Research Scholar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michaela Kiernan, PhD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37586
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.